New genetic variants could raise a woman’s risk of cervical cancer from HPV infections

Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.

Stelara Biosimilar OK’d With Interchangeability

A biosimilar version of the multipurpose biologic drug ustekinumab has been approved by the FDA and can be swapped interchangeably with the original product sold

November 2, 2023

How physical activity and diet impact sleep in adolescents

Researchers review the impact of physical activity and diet on the duration and quality of sleep among adolescents.

October 4, 2024

FDA delays enforcement of a pharmaceutical supply chain law to stop counterfeit drugs

In response to growing complaints, the U.S. Food and Drug Administration has postponed its plans to enforce a law designed to thwart counterfeit or diverted

August 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.